Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 218

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 6
Chunk 218
---
 with the right to exercise the award as to all or part of the shares, and may provide
for an acceleration of vesting of unvested awards, or (b) cancel the award and pay the grantee an amount in cash, our shares, shares of
the acquirer or of other corporation which is a party to such transaction or such other property as determined by the Administrator as
fair under the circumstances. Notwithstanding the foregoing: (1) the Administrator may upon such event of Merger/Sale amend, modify or
terminate the terms of any award as it shall deem, in good faith, appropriate and (2) the board of directors may determine, in its discretion,
that such transaction should be excluded from the definition of Merger/Sale set forth above.

2021 Share Incentive Plan

Upon closing of the Business
Combination, we adopted the 2021 Share Incentive Plan (the “2021 Plan”). The 2021 Plan provides for the grant of equity-based
incentive awards to our and our affiliates’ employees, directors, office holders, service providers and consultants in order to
incentivize them to increase their efforts on behalf of us or our affiliates and to promote the success of our business.

Authorized Shares.
As of December 31, 2024, there were 11,383,655 ordinary shares reserved and available for issuance under the 2021 Plan.

Shares Available for Grants.
As of January 1, 2025, the maximum number of ordinary shares available for issuance under the 2021 Plan is equal to the sum of (i) 23,794,633
ordinary shares plus (and without the need to further amend the 2021 Plan), (ii) any shares subject to awards under the 2016 Plan which
have expired, or were cancelled, terminated, forfeited or settled in cash in lieu of issuance of shares or became unexercisable without
having been exercised and (iii) an annual increase on the first day of each year beginning in 2024 and on January 1st of each calendar
year thereafter and through January 1, 2032, equal to the lesser of (A) 4% of our outstanding ordinary shares on the last day of the immediately
preceding calendar year; and (B) such amount as determined by our board of directors if so determined prior to January 1 of a calendar
year in which the increase will occur, provided that no more than 125